Hanauer SB
Is this you? Claim this profileThis page collects the articles indexed under the name Hanauer SB. Profiles are grouped by name, so it can include work by someone else who shares it until the author claims the profile and confirms which papers are theirs.
Publications 2
- Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial
- A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease
Is this you?
Claim this profile to connect it to your account. You will be able to remove papers that are not yours, fold in other spellings of your name, and show your affiliation and photo here.
Frequent co-authors
- Sandborn WJ 2
- Feagan BG 1
- Baker JP 1
- Cominelli F 1
- Sutherland LR 1
- Elson CO 1
- Salzberg BA 1
- Archambault A 1
- Bernstein CN 1
- Lichtenstein GR 1
- Heath PK 1
- Cameron S 1